Dyne Therapeutics, Inc. · NASDAQ:DYN
Point72 Asset Management, L.P. reported a 5.10% stake in Dyne Therapeutics, Inc. (Schedule 13G)
Event Jan 31, 2025 · Filed Feb 3, 2025
Point72 Asset Management, L.P. reported a 5.10% stake in Dyne Therapeutics, Inc., 5,196,597 shares, as a passive investor on Jan 31, 2025. Filed Feb 3, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 5,196,597
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.10% | 5,196,597 |
| Point72 Capital Advisors, Inc. | 5.10% | 5,196,597 |
| Steven A. Cohen | 5.10% | 5,196,597 |
Source
Related
- Dyne Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2025
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026